Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 2.550
+0.390 (18.06%)
At close: Mar 27, 2026
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 1.15 billion as of March 27, 2026. Its market cap has increased by 50.96% in one year.
Market Cap
1.15B
Enterprise Value
1.33B
Revenue
10.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.55
Market Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 1.15B, a decrease of -58.35%. That is a compound annual growth rate of -20.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.15B | 20.28% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunotech Biopharm | 1.72B |
| Cutia Therapeutics | 1.70B |
| Zhaoke Ophthalmology | 1.61B |
| CANbridge Pharmaceuticals | 1.54B |
| Beijing Biostar Pharmaceuticals | 1.39B |
| Kintor Pharmaceutical | 1.37B |
| 3D Medicines | 1.03B |
| Brii Biosciences | 1.01B |